IP Verse

Akebia Therapeutics competitive analysis

Loading summary...

Latest oppositions filed by Akebia Therapeutics

Explore patent oppositions filed by Akebia Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2324834
Methods Of Increasing Endogenous Erythropoietin (Epo)FIBROGENFeb 10, 2020
EP2289531
Medicaments For Increasing Endogenous Erythropoietine (Epo)FIBROGENApr 3, 2019
EP2298301
Medicaments For Increasing Endogenous Erythropoietin (Epo)FIBROGENApr 3, 2019
EP2322153
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGENJul 6, 2015

Latest patents of Akebia Therapeutics opposed by its competitors

Explore Akebia Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3007695
Feb 7, 2024Compositions And Methods For Treating Anemia1
EP3357911
May 11, 2022Prolyl Hydroxylase Inhibitors And Methods Of Use1
EP3277270
Oct 27, 2021Compositions And Methods For Treating Anemia1

Latest publications and patents of Akebia Therapeutics New

Explore the latest publications and patents granted to Akebia Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Akebia Therapeutics

EP3007695
Feb 7, 2024Compositions And Methods For Treating AnemiaGranted And Under Opposition
EP3357911
May 11, 2022Prolyl Hydroxylase Inhibitors And Methods Of UseGranted And Under Opposition
EP3277270
Oct 27, 2021Compositions And Methods For Treating AnemiaOpposition Rejected

Latest PTAB cases involving Akebia Therapeutics

Discover the latest PTAB cases involving Akebia Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Akebia Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AKEBIA THERAPEUTICS43 - -
FIBROGEN116 - 6
SANDOZ1181619 -